 |
6 Diseases |  |
0 Trials |
|
0 Trials |  |
6 News |  |
- | DiabeCell (immunoprotected [alginate-encapsulated] porcine islets) / Living Cell Technologies
Trial completion: Open-label Investigation of the Safety and Efficacy of DIABECELL in Patients With Type 1 Diabetes Mellitus (clinicaltrials.gov) - Mar 17, 2015
P2b, N=14, Completed, Sponsor: Living Cell Technologies
Active, not recruiting --> Completed
- DiabeCell (immunoprotected [alginate-encapsulated] porcine islets) / Living Cell Technologies
Trial completion: Open-label Investigation of the Safety and Effectiveness of DIABECELL (clinicaltrials.gov) - Aug 19, 2014
P1/2, N=8, Completed, Sponsor: Living Cell Technologies
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | DiabeCell (immunoprotected [alginate-encapsulated] porcine islets) / Living Cell Technologies
Trial completion: Open-label Investigation of the Safety and Effectiveness of DIABECELL(R) in Patients With Type I Diabetes Mellitus (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=16, Completed, Sponsor: Living Cell Technologies
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | DiabeCell (immunoprotected [alginate-encapsulated] porcine islets) / Living Cell Technologies
Enrollment closed: Open-label Investigation of the Safety and Efficacy of DIABECELL in Patients With Type 1 Diabetes Mellitus (clinicaltrials.gov) - Oct 19, 2013
P2b, N=20, Active, not recruiting, Sponsor: Living Cell Technologies
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- DiabeCell (immunoprotected [alginate-encapsulated] porcine islets) / Living Cell Technologies
New P1/2 trial: Open-label Investigation of the Safety and Effectiveness of DIABECELL (clinicaltrials.gov) - Dec 2, 2012
P1/2, N=8, Active, not recruiting, Sponsor: Living Cell Technologies
- | DiabeCell (immunoprotected [alginate-encapsulated] porcine islets) / Living Cell Technologies
New P2b trial: Open-label Investigation of the Safety and Efficacy of DIABECELL in Patients With Type 1 Diabetes Mellitus (clinicaltrials.gov) - Nov 27, 2012
P2b, N=20, Active, not recruiting, Sponsor: Living Cell Technologies